tiprankstipranks
Advertisement
Advertisement

AU:NOX Stock Latest News

Noxopharm Starts SOF-SKN Manufacturing Ahead of Cutaneous Lupus Trial
Company AnnouncementsNoxopharm Starts SOF-SKN Manufacturing Ahead of Cutaneous Lupus Trial
5d ago
NOX
Noxopharm Director Restructures Holding Via Off-Market Share Transfer
PremiumCompany Announcements
Noxopharm Director Restructures Holding Via Off-Market Share Transfer
13d ago
NOX
Noxopharm Showcases Potent New TLR8-Based Immuno-Oncology Platform
PremiumCompany Announcements
Noxopharm Showcases Potent New TLR8-Based Immuno-Oncology Platform
19d ago
NOX
Noxopharm Plans CEO Option Grant Tied to Long-Term Share Price Growth
PremiumCompany Announcements
Noxopharm Plans CEO Option Grant Tied to Long-Term Share Price Growth
1M ago
NOX
Noxopharm Taps Novotech to Advance SOF-SKN Toward Key FDA Milestone
PremiumCompany Announcements
Noxopharm Taps Novotech to Advance SOF-SKN Toward Key FDA Milestone
1M ago
NOX
Noxopharm Data Backs SOF-16’s Anti-Inflammatory Potential in Autoimmune Disease
PremiumCompany AnnouncementsNoxopharm Data Backs SOF-16’s Anti-Inflammatory Potential in Autoimmune Disease
1M ago
NOX
Noxopharm Names CFO Shawn van Boheemen as New Company Secretary
Premium
Company Announcements
Noxopharm Names CFO Shawn van Boheemen as New Company Secretary
1M ago
NOX
Noxopharm deepens Sofra push with Tezcat deal, CEO shift and key trial progress
Premium
Company Announcements
Noxopharm deepens Sofra push with Tezcat deal, CEO shift and key trial progress
2M ago
NOX
Noxopharm’s SOF-SKN shows prolonged skin retention in preclinical study
PremiumCompany Announcements
Noxopharm’s SOF-SKN shows prolonged skin retention in preclinical study
2M ago
NOX
Noxopharm Tightens Disclosure Controls After CEO Resigns and Director Notices Updated
PremiumCompany Announcements
Noxopharm Tightens Disclosure Controls After CEO Resigns and Director Notices Updated
2M ago
NOX
Noxopharm CEO Resigns as Biotech Awaits Successor Amid Strategic Shift
PremiumCompany Announcements
Noxopharm CEO Resigns as Biotech Awaits Successor Amid Strategic Shift
2M ago
NOX
Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
PremiumCompany Announcements
Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
4M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany AnnouncementsNoxopharm Issues 15 Million New Shares Under Financing Facility
4M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
Premium
Company Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
4M ago
NOX
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
Premium
Company Announcements
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
4M ago
NOX
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
PremiumCompany Announcements
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
4M ago
NOX
Noxopharm’s Sofra Platform Science Published in Top Immunology Journal
PremiumCompany Announcements
Noxopharm’s Sofra Platform Science Published in Top Immunology Journal
4M ago
NOX
Noxopharm Clears Key Safety Milestone as HERACLES Trial Concludes and Sofra Platform Gains Global Traction
PremiumCompany Announcements
Noxopharm Clears Key Safety Milestone as HERACLES Trial Concludes and Sofra Platform Gains Global Traction
4M ago
NOX
Noxopharm Clears Safety Milestone as HERACLES Trial for SOF-SKN Concludes
PremiumCompany Announcements
Noxopharm Clears Safety Milestone as HERACLES Trial for SOF-SKN Concludes
5M ago
NOX
Noxopharm Rolls Over $2.6m in Convertible Notes, Flagging Potential Share Dilution
PremiumCompany AnnouncementsNoxopharm Rolls Over $2.6m in Convertible Notes, Flagging Potential Share Dilution
5M ago
NOX
Noxopharm Issues New Unquoted Options and Convertible Notes
Premium
Company Announcements
Noxopharm Issues New Unquoted Options and Convertible Notes
5M ago
NOX
Noxopharm Redeems 2.6 Million Convertible Notes, Trimming Convertible Debt
Premium
Company Announcements
Noxopharm Redeems 2.6 Million Convertible Notes, Trimming Convertible Debt
5M ago
NOX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >